RxDoctor Payments Data

Elizabeth Hewitt, DPM

Foot & Ankle Surgery · Grove City, OHNPI 1679712152

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $263,943 of the $413,575 with a category attached, or 63.8%. 56 manufacturers reported payments, led by Flower Orthopedics Coporation at 42.6% of the total. Reporting peaked in 2020 at $97,039 and has fallen 78.1% since, to $21,250 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$413,575in general payments, 2019–2025

Across 545 payments — averaging $758.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Flower Orthopedics Coporation$176K
  • Smith+Nephew$37K
  • Integra Lifesciences Corporation$36K
  • Vilex LLC$32K
  • Gramercy Extremity Orthopedics LLC$30K
  • Linvatec Corporation$29K
  • plus $73K from 50 others
$50,000in ownership & investment interests, 2019–2025

Across 6 payments — averaging $8333.33 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$50K

What the payments were for

  • Royalty or licence$7,9512%
  • Consulting fees$263,94364%
  • Speaking & faculty fees$62,19015%
  • Grants$14,7504%
  • Travel & lodging$52,74613%
  • Food & beverage$11,9073%
  • Education$880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$413,575 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.

See all foot & ankle surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$67,514
Medicare patients
215
Services billed
971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate134$2,923
Etodolac89$2,287
Ketoconazole69$1,433
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen128$1,050
Cephalexin53$944
Gabapentin58$541
Methylprednisolone83$531
Doxycycline Hyclate34$437
CiclopiroxCiclopirox Olamine11$414
Ciclopirox11$274
Ibuprofen11$210
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$203
Terbinafine Hcl23$160
Clindamycin Hcl15$119
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$91

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Grove City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →